Holocene Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-79,036
| Closed | -$7.63M | – | 743 |
|
|
2024
Q3 | $7.63M | Buy |
79,036
+62,953
| +391% | +$6.08M | 0.03% | 280 |
|
|
2024
Q2 | $1.48M | Buy |
+16,083
| New | +$1.48M | 0.01% | 564 |
|
|
2024
Q1 | – | Sell |
-30,493
| Closed | -$2.9M | – | 699 |
|
|
2023
Q4 | $2.9M | Sell |
30,493
-17,433
| -36% | -$1.66M | 0.01% | 457 |
|
|
2023
Q3 | $4.48M | Buy |
+47,926
| New | +$4.48M | 0.02% | 401 |
|
|
2022
Q2 | – | Sell |
-9,413
| Closed | -$1.62M | – | 801 |
|
|
2022
Q1 | $1.62M | Buy |
+9,413
| New | +$1.62M | 0.01% | 578 |
|
|
2021
Q4 | – | Sell |
-35,669
| Closed | -$5.32M | – | 842 |
|
|
2021
Q3 | $5.32M | Buy |
35,669
+28,055
| +368% | +$4.18M | 0.03% | 315 |
|
|
2021
Q2 | $1.87M | Buy |
7,614
+1,183
| +18% | +$290K | 0.01% | 555 |
|
|
2021
Q1 | $1.7M | Buy |
+6,431
| New | +$1.7M | 0.01% | 609 |
|
|
2019
Q1 | – | Sell |
-3,584
| Closed | -$420K | – | 628 |
|
|
2018
Q4 | $420K | Buy |
+3,584
| New | +$420K | 0.01% | 458 |
|